Isamfazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C22H23N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XUW8L8PW09, chemically known as 1(6h)-pyridazineacetamide, n-methyl-n-alpha-methylphenethyl-6-oxo-3-phenyl-, l- but generally known as isamfazone, which bears US NIH Compound Identifier 68753. European Medicines Agency schedules Isamfazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08303MIG. The term ISAMFAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). ISAMFAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isamfazone under HS 29339990 and SITC 51577. As of Q4 2014, ISAMFAZONE remains the US FDA Preferred Term for this commodity. Isamfazone bears US NLM identifiers UMLS ID C0063884 and NCI Concept Code C80557. SMILES: O=C(N(C(CC1CCCCC1)C)C)CN1NC(CCC1=O)C1CCCCC1.